HCM
PFE icon

Highfields Capital Management’s Pfizer PFE Stock Holding History

Highfields Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,017,208
Closed -$96.2M – 72
2017
Q2 		$96.2M Hold
3,017,208
– – 0.71% 37
2017
Q1 		$97.9M Hold
3,017,208
– – 0.91% 29
2016
Q4 		$93M Hold
3,017,208
– – 0.77% 37
2016
Q3 		$97M Sell
3,017,208
-3,162,000
-51% -$106M 0.91% 33
2016
Q2 		$206M Hold
6,179,208
– – 1.8% 20
2016
Q1 		$174M Buy
+6,179,208
New +$177M 1.62% 23

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Highfields Capital Management's PFE Position: Q3 2017 in Review

Highfields Capital Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 3,017,208 shares — an estimated $96.2M sold.

Highfields Capital Management first reported a position in PFE in Q1 2016 and held it in 6 quarters. The position peaked at $206M in Q2 2016. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Highfields Capital Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Highfields Capital Management sold 3,017,208 Pfizer shares in Q3 2017, an estimated $96.2M.
  • Highfields Capital Management first reported a position in Pfizer in Q1 2016 and held it in 6 quarters.
  • Highfields Capital Management's Pfizer position peaked at $206M in Q2 2016.
  • 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Highfields Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.